Korea Investment Partners (KIP), the investment arm of financial services provider Korea Investment Holdings, has reached the final close of its fourth RMB-denominated fund at RMB1 billion (US$145.10 million) to invest in China’s biotech, healthcare and retail industries, said KIP in a statement released on its WeChat official account on December 24.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
